Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A ligand for human CD48 on epithelial cells

C J Ianelli1, C M Edson, D A Thorley-Lawson

  • 1Department of Pathology, Tufts University School of Medicine, Boston, MA 02111, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|October 23, 1997
PubMed
Summary

Researchers identified a novel ligand for human CD48 on epithelial cells, challenging previous understanding. This discovery suggests CD48 may mediate lymphocyte-epithelial cell interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A virtual look at Epstein-Barr virus infection: simulation mechanism.

Journal of theoretical biology·2008
Same author

Epstein-Barr virus: exploiting the immune system.

Nature reviews. Immunology·2002
Same author

Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.

Immunity·2001
Same author

Detection of EBV infection at the single-cell level. Precise quantitation of virus-infected cells in vivo.

Methods in molecular biology (Clifton, N.J.)·2001
Same author

Detection and discrimination of latent and replicative herpesvirus infection at the single cell level in vivo.

Methods in molecular biology (Clifton, N.J.)·2001
Same author

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.

Proceedings of the National Academy of Sciences of the United States of America·2000

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • CD48, an immunoglobulin superfamily member, shares homology with CD58.
  • In rodents, CD48 binds CD2, but human CD48 ligand remained elusive.
  • Previous research indicated CD58 as the human CD2 ligand.

Purpose of the Study:

  • To identify the ligand for human CD48.
  • To investigate the role of CD48 in cell adhesion.
  • To explore the interaction between CD48 and epithelial cells.

Main Methods:

  • Utilized a decameric, soluble CD48 IgM fusion protein to detect epithelial cell binding.
  • Employed monomeric CD48 immobilized on plastic dishes for binding assays.
  • Generated monoclonal antibodies (mAbs) against the identified ligand to block CD48 binding.

Related Experiment Videos

  • Investigated the role of CD44 in CD48-epithelial cell interactions.

    • Main Results:

    • Demonstrated the presence of a CD48 ligand on epithelial cells.
    • Confirmed that epithelial cells bind to both soluble and immobilized CD48.
    • Monoclonal antibodies against the ligand effectively blocked CD48 binding to epithelial cells.
    • Showed that CD44, specifically its glycosaminoglycan binding site, plays an auxiliary role in CD48 binding.
    • Found no interaction between human CD48 and CD2.

    Conclusions:

    • Human CD48 functions as an adhesion molecule by binding to a ligand on epithelial cells.
    • CD44 assists in the binding of epithelial cells to CD48.
    • This interaction suggests a novel role for CD48 in lymphocyte-epithelial cell communication.